Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice.

Blood
Dana HoserGerald Willimsky

Abstract

To date, little is known about the interaction between (pre-)malignant B cells and T cells. We generated transgenic mice that allow B cell-specific induction of the oncogene SV40 large T-antigen (TAg) to analyze the role of oncogene-specific T cells during sporadic B-cell lymphoma development. Constitutive TAg expression in CD19-Cre × LoxP-Tag mice resulted in TAg-tolerant CD8+ T cells and development of B-cell lymphomas. In contrast, CD19-CreERT2 × LoxP-Tag mice retained TAg-competent CD8+ T cells at time of oncogene induction and TAg expression in few B cells of adult mice resulted in exceptionally rare lymphoma formation late in life. Increased lymphoma incidence in the absence of TAg-specific T cells suggested T cell-mediated inhibition of lymphoma progression. However, TAg-initiated B cells were not eliminated by T cells and detected long term. Our results demonstrate a failure of the immune system to eradicate lymphoma-initiating B cells, retaining the risk of lymphoma development.

References

Nov 13, 1992·Science·E J Fuchs, P Matzinger
Jan 1, 1992·The Journal of Experimental Medicine·E E Eynon, D C Parker
Jul 21, 1988·Nature·O LassilaP Matzinger
Nov 1, 1985·The Journal of Experimental Medicine·C A MullenH Schreiber
Jun 1, 1995·Immunity·J E BuhlmannR A Flavell
May 1, 1994·The Journal of Experimental Medicine·W Y HoM M Davis
Mar 15, 1997·Nucleic Acids Research·R C RickertK Rajewsky
May 19, 1998·Nature Medicine·Z QinT Blankenstein
Dec 8, 1998·The Journal of Experimental Medicine·S R BennettW R Heath
Mar 4, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·J W HartleyT N Fredrickson
Oct 18, 2000·The Journal of Experimental Medicine·A L KovalchukH C Morse
Jul 14, 2001·Science·R M Zinkernagel, H Hengartner
Jul 24, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ann M RangerStanley J Korsmeyer
May 1, 1964·British Medical Bulletin·M BURNET
Jan 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Antje HeitHermann Wagner
Mar 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mara GerloniMaurizio Zanetti
Mar 10, 2004·The Journal of Experimental Medicine·Shayna E A StreetMark J Smyth
Sep 2, 2005·Nature·Gerald Willimsky, Thomas Blankenstein
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Giorgio RaimondiFrancesca Granucci
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Giorgio RaimondiFrancesca Granucci
Mar 24, 2007·Annual Review of Immunology·Andrew D HislopAlan B Rickinson
Jun 21, 2007·Nature Immunology·Marc Schmidt-Supprian, Klaus Rajewsky
Jun 25, 2008·The Journal of Experimental Medicine·Gerald WillimskyThomas Blankenstein
Sep 20, 2008·The Journal of Clinical Investigation·Takashi MatsushitaThomas F Tedder
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Friederike FrommerAri Waisman
Dec 24, 2010·Nature·Vu N NgoLouis M Staudt
Mar 5, 2013·The Journal of Clinical Investigation·Gerald WillimskyThomas Blankenstein
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Nov 19, 2013·Cold Spring Harbor Symposia on Quantitative Biology·Tomoharu YasudaKlaus Rajewsky
Dec 25, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ainhoa ArinaHans Schreiber
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Nov 10, 2015·The Journal of Clinical Investigation·Curtis J HenryJames DeGregori
Nov 5, 2016·The Journal of Experimental Medicine·Ana TextorThomas Blankenstein
Nov 20, 2016·Proceedings of the National Academy of Sciences of the United States of America·Tristan WirtzTomoharu Yasuda

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

The Journal of Clinical Investigation
Gerald WillimskyThomas Blankenstein
Immunological Reviews
Gerald Willimsky, Thomas Blankenstein
Proceedings of the National Academy of Sciences of the United States of America
M N Oxman, P H Black
Investigative Ophthalmology & Visual Science
K A HowesJ J Windle
© 2022 Meta ULC. All rights reserved